The disease-detecting devices that are currently being developed at Duke University’s Institute for Genome Science & Policy reminds me of "Precrime" incidents from the movie 'Minority Report.' Imagine a world in which illnesses can be diagnosed before they even happen?
Well, these disease-detecting devices are slightly more elementary. They find the illness before symptoms appear--not before the person actually becomes sick. Yet I still feel that it is paving the way for technology to do so in the near future.
Developed by Dr. Geoffrey Ginsburg and his team, the disease-detecting devices would "drastically improve clinical judgment in a day-to-day setting," according to Ginsburg. Essentially, it ascertains ailments via genetic markers nearly 24 hours before symptoms appear.
Disease-Detecting Devices
Researchers Develop Tech that Diagnoses Illness Before Symptoms Show
Trend Themes
-
Preemptive Diagnosis — Opportunity for companies to develop early detection devices that can identify diseases before symptoms appear.
-
Genetic Marker Testing — Companies can focus on developing tests that detect genetic markers of diseases before any symptoms occur.
-
Personalized Medicine — Companies can develop personalized medicine based on genetic markers and preemptively diagnose potential health risks.
Industry Implications
-
Healthcare — The healthcare industry can adapt preemptive diagnosis technologies to significantly improve patient outcomes.
-
Pharmaceuticals — Pharmaceutical companies can use genetic marker testing to develop drugs aimed at preventing various diseases.
-
Diagnostic Testing — Diagnostic testing companies have an opportunity to expand their offerings to include preemptive tests for genetic markers of diseases.